Identification of Licopyranocoumarin and Glycyrurol from Herbal Medicines as Neuroprotective Compounds for Parkinson's Disease

被引:26
作者
Fujimaki, Takahiro [1 ]
Saiki, Shinji [2 ]
Tashiro, Etsu [1 ]
Yamada, Daisuke [2 ]
Kitagawa, Mitsuhiro [1 ]
Hattori, Nobutaka [2 ]
Imoto, Masaya [1 ]
机构
[1] Keio Univ, Fac Sci & Technol, Dept Biosci & Informat, Yokohama, Kanagawa 223, Japan
[2] Juntendo Univ, Sch Med, Dept Neurol, Bunkyo Ku, Tokyo 113, Japan
关键词
COMPLEX-I DEFICIENCY; SUBSTANTIA-NIGRA; DOPAMINERGIC-NEURONS; MITOCHONDRIAL DYSFUNCTION; ANTIOXIDANT ACTIVITY; OXIDATIVE STRESS; PARS COMPACTA; SH-SY5Y CELLS; MOUSE MODEL; MPTP MODEL;
D O I
10.1371/journal.pone.0100395
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
In the course of screening for the anti-Parkinsonian drugs from a library of traditional herbal medicines, we found that the extracts of choi-joki-to and daio-kanzo-to protected cells from MPP+-induced cell death. Because choi-joki-to and daio-kanzo-to commonly contain the genus Glycyrrhiza, we isolated licopyranocoumarin (LPC) and glycyrurol (GCR) as potent neuroprotective principals from Glycyrrhiza. LPC and GCR markedly blocked MPP+-induced neuronal PC12D cell death and disappearance of mitochondrial membrane potential, which were mediated by JNK. LPC and GCR inhibited MPP+-induced JNK activation through the suppression of reactive oxygen species (ROS) generation, thereby inhibiting MPP+-induced neuronal PC12D cell death. These results indicated that LPC and GCR derived from choi-joki-to and daio-kanzo-to would be promising drug leads for PD treatment in the future.
引用
收藏
页数:12
相关论文
共 68 条
[11]   CHRONIC PARKINSONISM SECONDARY TO INTRAVENOUS-INJECTION OF MEPERIDINE ANALOGS [J].
DAVIS, GC ;
WILLIAMS, AC ;
MARKEY, SP ;
EBERT, MH ;
CAINE, ED ;
REICHERT, CM ;
KOPIN, IJ .
PSYCHIATRY RESEARCH, 1979, 1 (03) :249-254
[12]   Neuroprotective and neurorestorative strategies for Parkinson's disease [J].
Dawson, TM ;
Dawson, VL .
NATURE NEUROSCIENCE, 2002, 5 (Suppl 11) :1058-1061
[13]   BASAL LIPID-PEROXIDATION IN SUBSTANTIA NIGRA IS INCREASED IN PARKINSONS-DISEASE [J].
DEXTER, DT ;
CARTER, CJ ;
WELLS, FR ;
JAVOYAGID, F ;
AGID, Y ;
LEES, A ;
JENNER, P ;
MARSDEN, CD .
JOURNAL OF NEUROCHEMISTRY, 1989, 52 (02) :381-389
[14]   Neuroprotective effects of an herbal medicine, Yi-Gan San on MPP+/MPTP-induced cytotoxicity in vitro and in vivo [J].
Doo, Ah-Reum ;
Kim, Seung-Nam ;
Park, Ji-Yeon ;
Cho, Ki Ho ;
Hong, Jongki ;
Eun-Kyung, Kim ;
Moon, Sang Kwan ;
Jung, Woo Sang ;
Lee, Hyejung ;
Jung, Jae Han ;
Park, Hi-Joon .
JOURNAL OF ETHNOPHARMACOLOGY, 2010, 131 (02) :433-442
[15]   Apoptotic mechanisms and antiapoptotic therapy in the MPTP model of Parkinson's disease [J].
Eberhardt, O ;
Schulz, JB .
TOXICOLOGY LETTERS, 2003, 139 (2-3) :135-151
[16]   Mitochondrial function in Parkinson's disease cybrids containing an nt2 neuron-like nuclear background [J].
Esteves, A. Raquel F. ;
Domingues, A. Filipa ;
Ferreira, I. Luisa ;
Januario, Cristina ;
Swerdlow, Russell H. ;
Oliveira, Catarina R. ;
Cardoso, Sandra M. .
MITOCHONDRION, 2008, 8 (03) :219-228
[17]   Antioxidant activity of fraxetin:: In vivo and ex vivo parameters in normal situation versus induced stress [J].
Fernández-Puntero, B ;
Barroso, I ;
Iglesias, I ;
Benedi, J ;
Villar, A .
BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2001, 24 (07) :777-784
[18]  
Floor E, 1998, J NEUROCHEM, V70, P268
[19]   Role of JNK translocation to mitochondria leading to inhibition of mitochondria bioenergetics in acetaminophen-induced liver injury [J].
Hanawa, Naoko ;
Shinohara, Mie ;
Saberi, Behnam ;
Gaarde, William A. ;
Han, Derick ;
Kaplowitz, Neil .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (20) :13565-13577
[20]   Effects of Kampo extracts on drug metabolism in rat liver microsomes:: Rhei Rhizoma extract and Glycyrrhizae Radix extract inhibit drug oxidation [J].
Hasegawa, A ;
Kawaguchi, Y ;
Nakasa, H ;
Nakamura, H ;
Ohmori, S ;
Ishii, I ;
Kitada, M .
JAPANESE JOURNAL OF PHARMACOLOGY, 2002, 89 (02) :164-170